Fabien Praz

Showing 1-18 of 18 articles

Interventions for valvular disease

2021 ESC/EACTS Guidelines for the management of valvular heart disease

Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, Capodanno D, Conradi L, De Bonis M, De Paulis R, Delgado V, Freemantle N, Haugaa K, Jeppsson A, Jüni P, Pierard L, Prendergast B, Sádaba J, Tribouilloy C, Wojakowski W

December 22, 2021 | 10.4244/EIJ-E-21-00009

Five-year outcomes of mild paravalvular regurgitation after transcatheter aortic valve implantation

Okuno T, Tomii D, Heg D, Lanz J, Praz F, Stortecky S, Reineke D, Windecker S, Pilgrim T

December 22, 2021 | 10.4244/EIJ-D-21-00784

Impact of clinical presentation on bleeding risk after percutaneous coronary intervention and implications for the ARC-HBR definition

Gragnano F, Spirito A, Corpataux N, Vaisnora L, Galea R, Gargiulo G, Siontis G, Praz F, Lanz J, Billinger M, Hunziker L, Stortecky S, Pilgrim T, Bär S, Ueki Y, Capodanno D, Urban P, Pocock S, Mehran R, Heg D, Windecker S, Räber L, Valgimigli M

December 3, 2021 | 10.4244/EIJ-D-21-00181

Transcatheter treatment for tricuspid valve disease

Praz F, Muraru D, Kreidel F, Lurz P, Hahn R, Delgado V, Senni M, von Bardeleben R, Nickenig G, Hausleiter J, Mangieri A, Zamorano J, Prendergast B, Maisano F

November 19, 2021 | 10.4244/EIJ-D-21-00695

Outcomes of transcatheter tricuspid valve intervention by right ventricular function: a multicentre propensity-matched analysis

Schlotter F, Miura M, Kresoja K, Alushi B, Alessandrini H, Attinger-Toller A, Besler C, Biasco L, Braun D, Brochet E, Connelly K, de Bruijn S, Denti P, Estevez-Loureiro R, Fam N, Gavazzoni M, Himbert D, Ho E, Juliard J, Kalbacher D, Kaple R, Kreidel F, Latib A, Lubos E, Ludwig S, Mehr M, Monivas V, Nazif T, Nickenig G, Pedrazzini G, Pozzoli A, Praz F, Puri R, Rodés-Cabau J, Rommel K, Schäfer U, Schofer J, Sievert H, Tang G, Thiele H, Unterhuber M, Vahanian A, von Bardeleben R, von Roeder M, Webb J, Weber M, Wild M, Windecker S, Zuber M, Hausleiter J, Maisano F, Leon M, Hahn R, Lauten A, Taramasso M, Lurz P

July 20, 2021 | 10.4244/EIJ-D-21-00191

Transcatheter tricuspid valve treatment: does annular reduction make a difference?

Praz F, Brugger N

February 5, 2021 | 10.4244/EIJV16I15A219

Interventions for valvular disease

Transcatheter treatment of multivalvular heart disease

Winkel M, Brugger N, Hunziker L, Windecker S, Praz F

November 20, 2020 | 10.4244/EIJ-D-20-00244

Coronary interventions

Validation of the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria in patients undergoing percutaneous coronary intervention and comparison with contemporary bleeding risk scores

Ueki Y, Bär S, Losdat S, Otsuka T, Zanchin C, Zanchin T, Gragnano F, Gargiulo G, Siontis G, Praz F, Lanz J, Hunziker L, Stortecky S, Pilgrim T, Heg D, Valgimigli M, Windecker S, Räber L

August 28, 2020 | 10.4244/EIJ-D-20-00052

Optimal fluoroscopic viewing angles of right-sided heart structures in patients with tricuspid regurgitation based on multislice computed tomography

Xiong T, Pighi M, Thériault-Lauzier P, Leipsic J, Spaziano M, Martucci G, Buithieu J, Mousavi N, Pilgrim T, Praz F, Windecker S, Chen M, Piazza N

November 15, 2019 | 10.4244/EIJ-D-19-00618

Interventions for stroke

Second transcatheter closure for residual shunt following percutaneous closure of patent foramen ovale

Susuri N, Obeid S, Ulmi M, Siontis G, Wahl A, Windecker S, Nietlispach F, Meier B, Praz F

September 20, 2017 | 10.4244/EIJ-D-17-00061

Interventions for valvular disease

Prognostic impact of invasive haemodynamic measurements in combination with clinical and echocardiographic characteristics on two-year clinical outcomes of patients undergoing transcatheter aortic valve implantation

Franzone A, O’Sullivan C, Stortecky S, Heg D, Lanz J, Vollenbroich R, Praz F, Piccolo R, Asami M, Roost E, Räber L, Valgimigli M, Windecker S, Pilgrim T

April 7, 2017 | 10.4244/EIJ-D-16-00790

Interventions for valvular disease

Bilateral, reversible coronary obstruction during aortic valve-in-valve implantation of a repositionable valve system

Praz F, Moschovitis A, Stortecky S, Pilgrim T, Eberle B, Windecker S

October 20, 2016 | 10.4244/EIJV12I9A194

Interventions for valvular disease

Effect of resting heart rate on two-year clinical outcomes of high-risk patients with severe symptomatic aortic stenosis undergoing transcatheter aortic valve implantation

O’Sullivan C, Spitzer E, Heg D, Praz F, Stortecky S, Huber C, Carrel T, Pilgrim T, Windecker S

July 20, 2016 | 10.4244/EIJV12I4A83

Interventions for valvular disease

Transcatheter aortic valve implantation with the NVT Allegra transcatheter heart valve system: first-in-human experience with a novel self-expanding transcatheter heart valve

Wenaweser P, Stortecky S, Schütz T, Praz F, Gloekler S, Windecker S, Elsasser A

May 16, 2016 | 10.4244/EIJV12I1A13

A propensity score-matched comparison between Cardia and Amplatzer PFO closure devices - insights from the SOLUTION registry (Swiss percutaneOus patent foramen ovale cLosUre in recurrent clinical events prevenTION)

Puricel S, Arroyo D, Goy J-J, Praz F, Palhais N, Wahl A, Stauffer J-C, Togni M, Berger A, Meier B, Cook S

June 19, 2015 | 10.4244/EIJY14M05_05

Assessment of low-flow, low-gradient, severe aortic stenosis: an invasive evaluation is required for decision making

O’Sullivan C, Praz F, Stortecky S, Windecker S, Wenaweser P

September 27, 2014 | 10.4244/EIJV10SUA9

Transcatheter mitral valve implantation (TMVI) using the Edwards FORTIS device

Bapat V, Buellesfeld L, Peterson MD, Hancock J, Reineke D, Buller C, Carrel T, Praz F, Rajani R, Fam N, Kim H, Redwood S, Young C, Munns C, Windecker S, Thomas M

September 27, 2014 | 10.4244/EIJV10SUA18

Cerebral protection devices for transcatheter aortic valve implantation: is better the enemy of good?

Praz F, Nietlispach F

September 15, 2013 | 10.4244/EIJV9SSA26

1

Latest news

Three-year TAVI outcomes for BAV vs TAV

FREE ARTICLE - Dao Zhou et al.

January 20, 2022

Percutaneous management of left ventricular assist device outflow graft obstruction

FREE ARTICLE - Aleksandra Gasecka et al.

January 19, 2022

EuroCTO Club Consensus on Dual Lumen Microcatheters for CTO Recanalisation; Predicting Radial Crossover in ACS, the MATRIX score; DAPT duration for BRS; and more…

December 17, 2021

Lipid-rich plaque density and LDL-C in statin-treated vs statin-naïve patients

FREE ARTICLE - Rebecca Torguson et al.

January 17, 2022

Redo transcatheter mitral valve replacement in mitral annular calcification

FREE ARTICLE - Jennifer Jdaidani et al

January 13, 2022

TAVI vs SAVR in bicuspid aortic valve stenosis

FREE ARTICLE - Monil Majmundar et al.

January 12, 2022

Management of MR patients undergoing TMVI screening

FREE ARTICLE - Sebastian Ludwig et al.

January 7, 2022

Valvular disease